- Drug Coverage
- Hypertrophic Cardiomyopathy (HCM)
- Vaccines: 2023 Year in Review
- Eyecare
- Urothelial Carcinoma
- Women's Health
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Pulmonary Arterial Hypertension
- Safety & Recalls
- Biologics
- Asthma
- Atrial Fibrillation
- Type I Diabetes
- RSV
- COVID-19
- Cardiovascular Diseases
- Breast Cancer
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
Availability of Coverage Impacting Patients Seeking Infertility Treatment
A medical expert underscores the significance of infertility treatment coverage.
EP: 1.Clinician Challenges In Infertility Diagnosis
EP: 2.Emerging Trends and Technology Within Reproductive Medicine Landscape
EP: 3.Evaluating Access to Care and Service Coverage Associated With Reproductive Medicine
EP: 4.Availability of Coverage Impacting Patients Seeking Infertility Treatment
EP: 5.Strategies for Navigating Socioeconomic Factors In Reproductive Medicine
EP: 6.Optimizing Health Benefit Design and Patient Outcomes In Infertility Management
This expert perspective, provided by Joseph Chervenak, MD, MBA, illustrates the significant impact of infertility treatment coverage on decision-making, particularly in resource-limited populations. The focus is on the spectrum of infertility care, emphasizing alternatives to expensive treatments like IVF, such as oral medications (Clomid, letrozole) and intrauterine insemination (IUI). The influence of insurance mandates, requiring specific cycles of IUI before IVF, poses challenges for patients, affecting the success of the process, especially with aging. The introduction of frozen embryo transfer (FET) allows flexibility in timing, but insurance specifications play a role, with some requiring transfers within a specific timeframe. The evolving practice of vitrification for eggs and embryos raises questions about patient choices, including fertilization and potential options like donation or discarding. The complexity of these issues underscores the individualized nature of fertility treatments and the impact of external factors on patients' choices and outcomes.
Video synopsis is AI-generated and reviewed by Managed Health Care Executive editorial staff.
Can Lecanemab Succeed Where Aduhelm Failed?
September 28th 2022The announcement of positive phase 3 results for the investigational Alzheimer’s disease drug comes against a backdrop of Aduhelm flaming out. Both drugs are predicated on the theory that Alzheimer’s is caused by beta-amyloid deposits.
Read More
Value-Based Decision-Making in Metastatic Breast Cancer
September 16th 2021In this Managed Healthcare Executive® KCast, Ian Krop, M.D., Ph.D., oncologist and associate professor of medicine at Dana-Farber Cancer Institute in Boston, and Debra Patt, M.D., Ph.D., MBA, executive vice president at Texas Oncology in Austin, provide key insights into the value-based care model for patients with HER2-positive metastatic breast cancer (mBC). This article summarizes the highlights of the discussion.
Read More
